News
Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before Sen. Bernie Sanders' committee on the company's pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy ...
The vote that was scheduled for next week was preempted with the announcement that Novo Nordisk CEO Lars Fruergaard Jørgensen had agreed to testify before the Senate Health, Education, Labor and ...
The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices for weight ...
Norvo Nordisk (NVO) CEO agrees to testify before Senate on pricing strategy for weight loss drugs, Ozempic and Wegovy, avoiding subpoena. Read more here.
In a Senate hearing, the head of Novo Nordisk argued that higher prices were needed to ensure broader access to the drugs but committed to meeting with middlemen. IE 11 is not supported.
Bernie Sanders said the CEO of Novo Nordisk will testify on the cost of Ozempic and Wegovy. Lars Jørgensen will appear before the Senate Committee on Health, Education, Labor, and Pensions.
Novo Nordisk's top executive faced a Senate grilling over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic. The Danish drugmaker's CEO, Lars Fruergaard ...
Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy.Chairman Sen. Bernie Sanders, I-Vt ...
The CEO of Novo Nordisk plans to blame drug middlemen for the high cost of popular diabetes and weight loss drugs Ozempic and Wegovy during a Senate hearing Wednesday.
Jorgensen will testify before the committee, and the hearing will be held in early September. Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy Skip to main content ...
Novo Nordisk's top executive faced a Senate grilling over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic. The Danish drugmaker's CEO, Lars Fruergaard ...
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy. Stock Markets. Published 06/14/2024, 05:42 PM. Updated 06/14/2024, 06:35 PM.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results